EBLN3P and liver cancer: The study has found that the expression of miR-144-3p in patients with advanced liver cancer was significantly reduced, further evidence indicates that miR-144-3p targets the regulation of endogenous bornavirus-like nucleoprotein EBLN3P and dedicator of cytokinesis 4 DOCK4 to inhibit the proliferation and invasion of liver cancer cells.